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Acrosome reactionProteins known to function during cell–cell communication and exocytosis in neurons and other
secretory cells have recently been reported in human sperm. Synapsins are a group of proteins that
have been very well characterized in neurons, but little is known about synapsin function in other
cell types. Based upon previous findings and the known function of synapsin, we tested the hypoth-
esis that synapsin I was present in human sperm. Washed, capacitated, and acrosome induced sperm
preparations were used to evaluate the functional distribution of synapsin I using immunocyto-
chemistry. Protein extracts from mouse brain, mouse testis/epididymis, and human semen were
used for protein blotting techniques. Immunolocalization revealed synapsin I was enriched in the
sperm equatorial segment. Protein extracts frommouse brain, mouse testis/epididymis, and human
semen were positive for synapsin I using several different antibodies, and dot blot results were
confirmed by Western blot analyses. Finally, treatment of capacitated and acrosome reaction
induced samples with anti-synapsin antibodies significantly reduced sperm motility. Localization
of synapsin I in human sperm is a novel finding. The association of synapsin I with the sperm equa-
torial segment and effects on motility are suggestive of a role associated with capacitation and/or
acrosome reaction, processes that render sperm capable of fertilizing an oocyte.
 2015 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Successful fertilization involves species-specific communication
between the sperm and oocyte. In vivo, as sperm travel through the
female reproductive tract, a series of calcium dependent biochem-
ical changes, known collectively as capacitation, occur. Changes
include sterol oxidation and efflux from the membrane, movement
of lipid rafts, increase in intracellular cAMP, tyrosine phosphoryla-
tion, and hyperactivated motility [1]. Upon interaction with the
oocyte zona pellucida, sperm undergo acrosome reaction (AR); an
exocytotic process whereby the contents of the acrosome are
released. Previous studies have shown that both capacitation and
acrosome reaction are necessary for sperm to acquire the ability
to fertilize an oocyte [2,3]. Vesiculation of the sperm membrane
and simultaneous release of the acrosomal contents could be
likened to the release of signaling substances as a means of
cell–cell communication in other cell types. This communication
must be efficient, reliable, and carefully regulated. Exocytosis andrelease of signaling substances in neurons have been studied in
detail. One group of proteins implicated in these processes are
synapsins. The synapsins arise from three separate genes in verte-
brates, and multiple isoforms exist due to alternative splicing
[4–6]. Synapsin I has two isoforms, Ia and Ib, with molecular
weights of 86 and 80 kDa respectively [7]. Synapsin I was discov-
ered as a phosphorylation target dependent on cAMP [7–9], and
later as a phosphorylation target of Ca2+-calmodulin dependent
protein kinases [10–12]. Synapsin I is highly abundant in both
peripheral and central nervous systems. It is associated with small
synaptic vesicles within presynaptic terminals but dissociates
upon calcium dependent phosphorylation [13–18]. Several studies
have shown that synapsin I interacts with actin, which changes
upon phosphorylation [19–23]. Synapsin I is thought to create a
reserve pool of vesicles by binding to synaptic vesicles and actin.
Upon phosphorylation following calcium influx, synapsin I dissoci-
ates from synaptic vesicles and actin, allowing vesicle mobilization
and subsequent release. Additionally, synapsins play roles in neu-
ronal growth, development, and synapse formation [24–28]. Early
studies suggested synapsin proteins were neuron specific
[7,9,29,30], and little is known about their function in non-
neuronal cells. Synapsin I has been characterized in cell lines of
non-neuronal origin, such as AtT-20 cells [31] and PC12 cells trea-
ted with NGF [32,33]. Synapsin I has been implicated in insulin
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ules or other vesicular structures is unclear [34–37]. Synapsin I
has also been reported in cultured astrocytes [38], liver, NRK
epithelial cells [39,40], and osteoblasts [41].
Rab3a and Munc13, whose respective functions in synaptic
vesicle targeting and priming in neurons are well known [42,43]
also regulate secretion in bovine chromaffin cells [44–46] and
insulin release [47,48]. The interaction and functions of several
key secretory regulators have been investigated in acrosomal exo-
cytosis in human sperm [49–51]. Recently, Rab3a, Munc13, and
RIM have been reported in human sperm with functions during
acrosomal exocytosis [49,51]. These findings led to our hypothesis
that synapsin proteins may be present in human sperm. The pur-
pose of this study was to investigate the localization and functional
distribution of synapsin I in washed, capacitated, and acrosome
induced human sperm. Additionally, we evaluated sperm motility
following capacitation and acrosome reaction in the presence and
absence of anti-synapsin antibodies. Results reported herein
revealed synapsin I enrichment in the sperm equatorial segment.
Inclusion of anti-synapsin antibodies during capacitation and acro-
some reaction significantly reduced sperm motility.
2. Materials and methods
2.1. Semen sample collection
Human semen samples were collected with written consent
from volunteers 18 years of age and older. All experimental proce-
dures involving human samples were approved by the Bloomsburg
University Institutional Review Board (approved protocol # 2013-
4). All samples were de-identified such that volunteer confidential-
ity was maintained, and samples were assigned a random study
identification code. Whole semen was analyzed within 1–2 h of
collection. Total sample volume, pH, total cell count, and percent
motility were recorded.
2.2. Sperm sample preparation
Washed human sperm were prepared by placing 1.5 mL of
whole, human semen into a 15 mL conical tube with 5 mL of
human sperm medium (HSM) [52]. The sample was then cen-
trifuged for 10 min, 500g at room temperature (RT). The super-
natant was carefully decanted and the sperm pellet was
resuspended in 1.5 mL HSM. For capacitation, 1 mL of washed
sperm was mixed with 1 mL of HSM with 7% BSA and incubated
3–4 h at 37 C with 5% CO2. Following capacitation, the sample
was microscopically observed for the presence of hyperactivation.
Only samples with at least 50% motility were utilized for acrosome
reaction induction. Capacitated sperm were induced to undergo
acrosome reaction by incubation with 10 lM bromo-A23187 iono-
phore (EMD Millipore Corporation) for 30 min at 37 C with 5%
CO2.
2.3. Protein extract preparation
2.3.1. Extraction buffer
Protein extraction was conducted using chilled RIPA buffer.
Briefly, RIPA buffer was prepared in sterile 1X PBS and contained
1% Nonidet-P40 (Fisher Scientific), 0.5% deoxycholic acid sodium
salt (Fisher Scientific), 0.1% sodium dodecyl sulfate (SDS) (Thermo
Scientific), and 1X protease inhibitor cocktail (Sigma–Aldrich).
2.3.2. Protein extracts from mouse samples
All experimental procedures involving animal samples were
approved by the Bloomsburg University Institutional Animal Care
and Use Committee (protocol # 106). All tissues were extractedpost-mortem from male mice (Harlan Laboratories, Hsd:ICR,
CD-1) that were rapidly euthanized with an overdose of the inha-
lant anesthetic halothane, in accordance with the IACUC protocol.
Protein extracts for dot blot and Western blot analyses were
prepared from mouse brain and mouse testis/epididymis (T/E).
Tissue was harvested from six different mice on separate occasions.
For each mouse, extracts were prepared individually and samples
were not pooled. Brain and T/E extracts from three different mice
were utilized for the experiments presented herein and representa-
tive results are shown. The entire brain or T/E dissected from each
mouse was weighed and 10 lL of RIPA buffer were added per mg of
tissue. Samples were homogenized using a Polytron tissue
homogenizer for 10 s. Following homogenization, samples were
centrifuged for 20 min, 16,000g at 2 C. The supernatant was dec-
anted and placed into sterile cryovials and used for dot andWestern
blot analyses. Total protein was quantified by bicinchoninic acid
(BCA) assay. Samples were diluted with 1X PBS. Ten microliters of
each sample were placed into a well of a micro-plate, mixed with
200 lL PierceTM BCA working reagent (Thermo Scientific), and incu-
bated for 60 min at 37 C with shaking. Samples were run in
triplicate. Absorbance was quantified at 570 nm using a Tecan
GENios Plus plate reader. Total protein was determined by
comparison to bovine serum albumin (BSA) standard curve.
2.3.3. Protein extracts from human semen
Human sperm and seminal plasma extracts were prepared by
pooling whole semen samples from the same donor collected on
separate days. For each sample, 1.5 mL of whole semen (approxi-
mately 62,000,000 sperm cells) were placed into a sterile micro-
fuge tube and centrifuged at 6000g for 15 min. The top 500 lL
of supernatant were decanted and placed into a new microfuge
tube containing 500 mL of RIPA buffer with 1X protease inhibitor.
This sample was labeled as seminal plasma and frozen at 80 C.
The remaining supernatant was discarded and the pellet was
resuspended with 250 lL of RIPA buffer with 1X protease inhibitor.
This sample was labeled as sperm pellet and frozen at 80 C. The
second semen sample from the same donor was prepared follow-
ing the above protocol. The first two samples were thawed and
added to either the previous seminal plasma or sperm pellet
extracts. Samples were then referred to as pooled seminal plasma
or pooled sperm cell. Each pooled sample was sonicated at 9 V for
45 s. The samples were centrifuged at 15,000g for 10 min. The top
400–500 lL of supernatant were reserved, placed into a new cry-
ovial, and used for subsequent dot and Western blot analysis. Total
protein was quantified using BCA assay as previously described.
2.3.4. Dot blot
Protein extracts from mouse brain, mouse T/E, human sperm
cells, and human seminal plasma were spotted three times onto
a piece of 0.20 lm nitrocellulose membrane (Thermo Scientific)
in 2 lL aliquots, with drying time between applications. Vertical
pencil lines were hand-drawn on each blot to delineate the area
in which each sample was applied. All samples were applied to a
single, continuous blot. The membrane was wet in 1X PBST
(1X PBS containing 0.1% Tween-20 (Fisher Scientific)), placed into
a 10 cm petri dish, and blocked for 1 h with 10 mL of 5% milk in
1X PBST on a shaker at RT. Following blocking, milk was poured
off and 10 mL of primary polyclonal goat anti-synapsin Ia/b A-15
antibody (Santa Cruz Biotechnology Cat# sc-55774), polyclonal
rabbit anti-synapsin Ia/b H-170 antibody (Santa Cruz Biotechnol-
ogy Cat# sc-20780), or monoclonal mouse anti-synapsin Ia/b
B-11 antibody (Santa Cruz Biotechnology Cat# sc-376622) were
added. A-15 was raised against a peptide near the C-terminus of
human synapsin Ia, H-170 was raised against amino acids
491–660 at the C-terminus of human synapsin Ia/b, and B-11
was raised against amino acids 2–29 at the N-terminus of human
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tration of 1 lg/mL. The anti-synapsin A-15 and H-170 antibodies
have been previously shown to be specific for synapsin Ia/b in
immunoblotting [53,54].
Membranes were incubated for 2 h at RT with shaking. Primary
antibodies were poured off and the membrane was washed three
times, five minutes per wash, with 1X PBST. Ten milliliters of
secondary antibody rabbit anti-goat IgG (H + L) conjugated to
horseradish peroxidase (HRP) (KPL, 14-13-06, Lot # 121056), goat
anti-rabbit IgG (H + L) conjugated to HRP (KPL, 04-15-06, Lot #
101132), or goat anti-mouse IgG (gamma) conjugated to HRP
(KPL, 074-1802, Lot # 130639) were added (0.2 lg/mL final con-
centration). Membranes were incubated for 1 h at RT with shaking.
Secondary antibody was poured off and membranes were washed
twice with 1X PBST and once with 1X PBS, five minutes per wash.
One milliliter of TMB Membrane Peroxidase Substrate (KPL) was
pipetted onto each blot and incubated for 3 min in the dark. Sterile,
distilled water was poured onto the blot to stop the reaction.
Development of color was documented digitally using an Alpha
Innotech gel imaging system. Densitometry was performed using
FluorChem HD software to determine mean pixel intensity for each
sample. Equal areas for each sample were analyzed. All samples
within the same dot blot were normalized to RIPA (average pixel
intensity of sample  average pixel intensity of RIPA). Microsoft
Excel was used to generate graphs. Dot blot analysis with each
antibody was performed in triplicate using samples from different
donors. Representative dot blots are shown. All primary antibodies
were diluted in 5% milk in 1X PBST and all secondary antibodies
were diluted in 1X PBST.
2.3.5. SDS–polyacrylamide gel electrophoresis (SDS–PAGE) and
western blot
SDS–PAGE was performed using a vertical gel apparatus (Fisher
Scientific) with pre-cast NuPAGE 4–12% Bis-Tris gels (Novex by Life
Technologies). Protein extracts were prepared as described above
for dot blot analysis. Synapsin Ia/b (m): 293T lysate (Santa Cruz
Biotechnology) was loaded as a positive control. Each extract was
diluted with NuPAGE LDS Sample Buffer (Novex by Life Technolo-
gies), NuPAGE Sample Reducing Agent (Invitrogen), and sterile dis-
tilled water according to the manufacturer’s instructions, and
heated at 70 C for 10 min. Fifteen microliters of kaleidoscope pre-
stained protein standard (BioRad) or 25 lL of each protein extract
were loaded and subjected to electrophoresis in 1X NuPAGE MOPS
SDS Running Buffer (Novex by Life Technologies) with NuPAGE
antioxidant (Invitrogen) at 200 V for 25–30 min. Following separa-
tion, proteins were electrotransferred onto 0.2 lm nitrocellulose
membrane in 1X NuPAGE Transfer Buffer (Novex by Life Technolo-
gies) at 30 V for 1 h. The ladder can sometimes fade during mem-
brane processing; therefore, pencil lines were drawn on the
nitrocellulose to the right of the bands after transferring to mark
their position. Membranes were blocked with 5% milk powder in
1X PBST and incubated for 1 h at RT with shaking. Ten milliliters
of primary polyclonal rabbit anti-synapsin Ia/b H-170 antibody
(1 lg/mL) in 5% milk with 1X PBST were added to the membrane
and incubated at 4 C for 20 h with shaking. The primary antibody
was poured off and the membrane was washed three times, five
minutes per wash, with 1X PBST. Ten milliliters of secondary anti-
body goat anti-rabbit IgG (H + L) conjugated to HRP (0.2 lg/mL)
in 1X PBST were added to the membrane and incubated for 1 h
at RT with shaking. The secondary antibody was poured off and
the membrane was washed twice with 1X PBST and once with
1X PBS, five minutes per wash. Two milliliters of TMB Membrane
Peroxidase Substrate were pipetted onto the membrane and
incubated for 5 min in the dark. Sterile, distilled water was poured
onto the membrane to stop the reaction. Development of color was
documented digitally and the figure was assembled using AdobePhotoshop CC. Western blot analysis was performed multiple
times on separate occasions using samples from different donors
to confirm results.
2.4. Immunocytochemistry
Eight microliters of washed (approximately 320,000 cells),
capacitated (approximately 240,000 cells), or acrosome induced
(approximately 208,000 cells) human sperm were applied to Fluo-
rescent Antibody Rite-On Microslides (Gold Seal), allowed to air
dry, and fixed with 100% methanol for 10 min. All staining proce-
dures were performed at RT in a humidified slide box. Slides were
moistened with 1X PBS and covered with a blocking solution con-
taining either 5% normal goat serum (Invitrogen) or 5% milk. One
hundred microliters of primary polyclonal rabbit anti-synapsin
Ia/b H-170 antibody (20 lg/mL) were applied to each slide. The
anti-synapsin H-170 antibody has been previously shown to be
specific for synapsin Ia/b in immunostaining [55,56].
Slides were incubated for 1–2 h then rinsed three times with 1X
PBS. Fluorescently tagged secondary goat anti-rabbit IgG (H + L)
conjugated to Alexa Fluor 488 (Molecular Probes/Life Technolo-
gies) was applied to each slide at a final concentration of
4 lg/mL in PBS and incubated for 1 h. Control slides were treated
with 1X PBS alone during the primary antibody step. For some
experiments, slides were doubly labeled with RITC conjugated lec-
tin from Pisum sativum (RITC-PSA) (Vector Laboratories) to evalu-
ate membrane status. Thirty-five microliters of RITC-PSA (20 lg/
mL) were added to the slides and incubated for 30 min at RT. Fol-
lowing several rinses, slides were covered with Mowiol and a No. 1
coverslip (Fisher Scientific). Slides were analyzed using a Zeiss LSM
510 Meta confocal microscope equipped with a 63X oil objective.
Images were acquired in multi-track mode using Zen 2008 soft-
ware. Figures were assembled using Adobe Photoshop CC.
Immunocytochemistry experiments were performed using sam-
ples from multiple donors and representative results are shown.
2.5. Sperm motility assay
For some experiments, sperm were capacitated and acrosome
induced in the presence of the polyclonal goat anti-synapsin Ia/b
A-15 antibody or the polyclonal rabbit anti-synapsin Ia/b H-170
antibody (20 lg/mL). Following each treatment, percent motility
was microscopically quantified using a Cell Vu counting chamber
and gridded coverslip. The number of motile and non-motile sperm
was recorded from representative fields in each sample. Sperm
making forward progress were classified as motile. Sperm motility
was documented by placing 10 lL of each treatment into a Cell Vu
counting chamber with non-gridded coverslip. Video micrographs
were captured using a Nikon microscope equipped with a Sony
Exwave HAD DSP 3CCD color video camera. Percent motility was
calculated by dividing the number of motile sperm by the total
number of sperm counted. Average cell concentration for motility
assays was 23–30 million cells/mL for A-15 and 20–25 million
cells/mL for H-170 experiments. Descriptive statistics and paired
t-tests were performed using SigmaPlot 12.5 and Microsoft Excel.
Significant differences were at or below p 6 0.05.
3. Results
By visual interpretation, dot blot analysis using polyclonal anti-
bodies H-170 (Fig. 1A) and A-15 (Fig. 1C) and monoclonal antibody
B-11 (Fig. 1E) revealed synapsin I was present in mouse brain,
mouse T/E, sperm cell, and seminal plasma fractions. Fig. 1 shows
single, continuous dot blots probed with each antibody. As
expected in all blots, synapsin I was present in mouse brain (pos-
itive control) and absent in RIPA buffer with 1X protease inhibitor
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Fig. 1. Dot blot analysis revealed the presence of synapsin I in human sperm. RIPA (1), mouse brain (2), mouse T/E (3), human sperm (4), and human seminal plasma (5)
samples were blotted onto nitrocellulose and probed with anti-synapsin Ia/b antibody H-170 (A), A-15 (C), or B-11 (E). Data were normalized to RIPA and presented as
average pixel intensity per lg protein blotted (B, D and F). Error bars denote standard error.
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the C-terminus of synapsin Ia/b, whereas monoclonal antibody
B-11 recognizes the N-terminus. Densitometry was performed to
quantify average pixel intensity and normalized to RIPA. Total
protein was determined using BCA and calculated by comparison
to BSA standard curve (R2 = 0.98). Average pixel intensity per lg
protein blotted is shown (Fig. 1B, D and F) for blots probed with
H-170, A-15, and B-11 respectively. This analysis was consistent
with visual interpretation of the blots. Results from dot blot
analysis were consistent over multiple replicates using samples
from different donors. Taken together, antibodies raised against
the C-terminus and N-terminus support the presence of synapsin
I in human sperm.
Western blots were performed to confirm dot blot results.
Results from a typical Western blot using H-170 antibody are
shown (Fig. 2). As expected, an intense band was present in the
lysate and the mouse brain lanes (positive controls). These bands
were within the expected molecular weight range (75–100 kDa),
as synapsin Ia/b is 80/86 kDa in size. Although these bands appear
to be closer to the 75 kDa marker on the gel, this could be due to
experimental variation during electrophoresis and electrotransfer.
These positive control bands were consistently present for all Wes-
tern blots performed. The bands present in the mouse T/E, human
pellet, and seminal plasma lanes (Fig. 2, brackets) closely corre-
spond to those in the lysate and mouse brain lanes (positive con-
trols). Although the band from the pellet sample was faint, it was
consistently present across multiple replicates and donors. Bands
of lower molecular weight (37–75 kDa) were also present in all
samples except the lysate. These lower molecular weight bands
were not unexpected, as they are reported on the H-170 antibody
data sheet from the manufacturer. These lower molecular weight
bands could represent degradation products of synapsin I, or differ-
ent isoforms specific to these samples. Additional experiments
would be required to confirm the presence of a novel isoform in
sperm; however, this was beyond the scope of the present study.
Results from Western blot analyses were consistent over multiple
replicates using samples from different donors. Similar results
were obtained by probing nitrocellulose membranes with anti-
synapsin antibody A-15 (data not shown). Although bands in the
correct molecular weight range were noted, increased background
was apparent with this antibody. Data from these experiments
provided a second line of evidence confirming the presence of
synapsin I in human sperm.
Immunolocalization using washed, capacitated, and acrosome
induced human sperm preparations was performed and results
shown in Fig. 3. Slides were doubly labeled with RITC-PSA toFig. 2. Western blot analysis confirmed the presence of synapsin I in human sperm.
Membranes probed with anti-synapsin Ia/b H-170 antibody showed bands of the
expected size (75–100 kDa) in synapsin Ia/b transfected lysate (1), human seminal
plasma (2), human pellet (3), mouse T/E (4), and mouse brain (5) lanes. No bands
were present in RIPA buffer (6, negative control). Lanes 1 and 5 were positive
controls. L = protein standard ladder.evaluate the status of the acrosomal membrane. Previous studies
have shown that labeling sperm with lectin from Arachis hypogea
(PNA) and P. sativum (PSA) are useful markers to evaluate the sta-
tus of acrosomal membranes [57,58]. Synapsin I staining varied
slightly depending upon the functional state of the sperm. Washed
human sperm probed with H-170 antibody revealed staining in the
sperm equatorial segment (Fig. 3A). The intensity of the stain var-
ied depending upon the status of the acrosomal membranes. Cells
in which the entire head was brightly and evenly stained with
RITC-PSA showed light synapsin I staining. Sperm with diffuse
RITC-PSA staining, denoting changes in the sperm membranes,
showed a brighter band in the equatorial segment. These results
were not unexpected, as previous studies have shown that in a
given population of motile sperm, not all sperm undergo acrosome
reaction and some spontaneously react [59]. Each sample analyzed
will therefore contain sperm at various functional states. Capaci-
tated and acrosome induced preparations revealed bright synapsin
I staining in the equatorial segment (Fig. 3B and C). RITC-PSA stain-
ing was diffuse, with some cells unstained and some with equato-
rial bands. These staining patterns were expected, as the acrosomal
membranes change during capacitation and acrosome reaction
induction. Slides incubated with secondary antibody alone (con-
trol) revealed some background staining that was not associated
with sperm (this non-specific background staining was noted for
all experiments). Representative control fields selected at random
for washed, capacitated, and acrosome induced preparations are
shown in Fig. 3 as an overlay of the fluorescence and DIC channels.
Similar results were obtained from immunolocalization experi-
ments using the A-15 antibody (results not shown). As the sperm
membrane status changes and the equatorial segment becomes
more accessible, the intensity of the synapsin staining increased.
Results from these experiments clearly document the localization
of synapsin I in the human sperm equatorial segment.
Data evaluating the functional role of synapsin in human sperm
are shown in Fig. 4. Sperm were capacitated and induced to
undergo acrosome reaction in the absence and presence of anti-
synapsin A-15 (Fig. 4A) or H-170 (Fig. 4B) antibody. Following each
treatment, percent motility was microscopically quantified using a
Cell Vu counting chamber and gridded coverslip. The number of
motile and non-motile sperm was recorded from representative
fields in each sample. Fig. 4 shows a significant decrease in average
percent motility for preparations capacitated and acrosome
induced in the presence of A-15 and H-170. Capacitation in the
presence of A-15 antibody decreased motility 23% (p = 0.0002)
and the presence of H-170 decreased motility 27% (p = 0.004) com-
pared to the control. A significant decrease in sperm motility was
also noted during acrosome reaction induction. In the presence of
A-15 antibody, motility decreased 16% (p = 0.003), and 27% in the
presence of H-170 antibody (p = 0.002) compared to the untreated
control. A classic sign of successful capacitation is sperm hyperac-
tivation, in which the flagellar motion becomes asymmetrical with
high amplitude [2]. In both the control and antibody treated sam-
ples, hyperactivated sperm were present; however, the sperm in
the antibody treated preparations appeared sluggish upon micro-
scopic observation. Video micrographs documenting motility for
each treatment can be found in Supplementary files (S1–S6). We
hypothesize that treatment with synapsin I antibody may have
reduced sperm motility by disrupting actin polymerization. Previ-
ous studies have shown a relationship between actin polymeriza-
tion and hyperactive sperm motility during capacitation.
4. Discussion
The purpose of this study was to investigate the localization and
functional distribution of synapsin I in human sperm. Data pre-
sented herein supported our hypothesis that synapsin I is present
Fig. 3. Immunolocalization revealed enrichment of synapsin I in the equatorial segment of human sperm. Washed human sperm labeled with anti-synapsin Ia/b antibody
H-170 and RITC-PSA (A) showed localization to the sperm equatorial segment. Similarly, capacitated and acrosome induced sperm preparations showed bright staining in the
sperm equatorial segment (B and C). In each series, the first four panels represent the same confocal field. The fifth panel shows a representative field from a secondary
antibody only (control) slide. Note the background staining is not associated with sperm. Scale bar = 10 lm.
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localized to the sperm equatorial segment; with the brightest
staining in capacitated and acrosome induced cell preparations.
Dot blot techniques using antibodies against the C-terminus and
N-terminus demonstrated positive results in human sperm cell,
human seminal plasma, mouse T/E, and mouse brain extracts.
Densitometry data supported the visual interpretation of the dot
blots indicating the presence of synapsin I in all samples except
RIPA (negative control). Western blotting techniques revealed a
band between 75 and 100 kDa for mouse T/E, human pellet, and
human seminal plasma extracts. These bands closely corresponded
to the intense band present in the lysate and mouse brain lanes,
confirming that the detected protein was synapsin I. The presence
of synapsin I in the seminal plasma shown by both dot blot and
Western blot techniques was likely protein from the sperm cells
and not a soluble form of synapsin I. When preparing the protein
extracts, it is possible that some sperm cells could have contami-
nated the seminal plasma fraction, even though microscopic
inspection of a small aliquot showed no sperm present. Addition-
ally, sperm cells may have been damaged during centrifugation,
thereby causing the release of synapsin I into the supernatant.
Studies investigating the source of the synapsin I in the seminal
plasma extracts were outside the scope of this study.
Since their initial discovery, synapsins have been extensively
studied in neurons. The localization of synapsin I in human sperm
is a novel finding. Enrichment within the sperm equatorial seg-
ment is provocative, as this part of the sperm remains intact fol-
lowing AR and is the site of sperm-oocyte membrane fusion [60].
The precise function of synapsin I in sperm is unknown. Based
upon its localization to the equatorial segment in capacitated andacrosome induced preparations, as well as previous findings in
other secretory cells, we hypothesize two functions for synapsin
I. In its dephosphorylated form, synapsin I has been shown to bun-
dle F-actin [19,20,61]. Calcium dependent phosphorylation of
synapsin I results in the dissociation of synapsin from actin [19].
It has been reported that actin polymerization occurs during capac-
itation, and prior to AR, there is a rapid depolymerization of F-actin
[62]. It is possible that synapsin I functions by stabilizing and/or
bundling F-actin. Upon calcium influx, synapsin I could become
phosphorylated by calcium-dependent kinases, acting as a trigger
for F-actin depolymerization, allowing the AR to occur. Data
reported herein documented a significant decrease in sperm motil-
ity following capacitation and induction of acrosome reaction in
the presence of anti-synapsin antibodies. This further supports
the notion that synapsin could be involved in regulating cytoskele-
tal dynamics during these processes.
The AR is an exocytotic event involving fusion of sperm mem-
branes and formation of vesicles [2,63]. Another possible function
of synapsin I could be associated with sperm membrane dynamics.
Synapsin I, in a dephosphorylated state, could stabilize the sperm
membranes. Calcium influx during capacitation could lead to the
phosphorylation of synapsin I, thereby causing a re-distribution
of the protein, as observed in neurons [16,17,64]. This may cause
the sperm membranes to become unstable, promoting fusion of
membranes and subsequent vesiculation. Synapsin I is not only a
target of calcium/calmodulin dependent kinases, but it can also
be phosphorylated by PKA, MAPK, cyclin dependent kinase 5
(cdk5) [65] and by tyrosine kinases [66]. The latter may be of par-
ticular interest, as tyrosine kinase phosphorylation has been
strongly implicated in sperm capacitation [1].
Fig. 4. Capacitation and induction of acrosome reaction in the presence of anti-
synapsin antibodies A-15 and H-170 significantly reduced sperm motility. Human
sperm were capacitated (Cap) and induced to undergo acrosome reaction (AR) in
the absence (solid bars) and presence (striped bars) of A-15 and H-170. An *
indicates a significant difference between treated and untreated samples using a
paired t-test ((A-15: Cap p = 0.0002, AR p = 0.003); (H-170: Cap p = 0.0004, AR
p = 0.002)). Seven samples from five different donors were analyzed for A-15 and six
samples from three different donors were analyzed for H-170. Error bars represent
standard error.
W.L. Coleman et al. / FEBS Open Bio 5 (2015) 801–808 8075. Conclusions
Multiple lines of evidence clearly support the presence of
synapsin I in the human sperm equatorial segment. Functional
studies suggest a potential role during capacitation and/or acro-
some reaction. These novel findings add to our current understand-
ing of sperm morphology and architecture. Understanding gamete
structure is key to understanding the molecular events of fertiliza-
tion. Unraveling the specific function of synapsin I during capacita-
tion and/or acrosome reaction is the focus of future studies.
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